Form 4: Fulgent Genetics CSO Sells Shares for Tax Obligations
Insider Transaction Report
Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, reported the disposition of common stock shares to cover tax withholding obligations related to vested restricted stock units.
Summary
- Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, Inc. (FLGT), reported three separate dispositions of common stock.
- On February 26, 2026, 897 shares were disposed of at a price of $24.76 per share to satisfy tax withholding obligations from restricted stock units (RSUs) granted on February 26, 2024.
- On March 1, 2026, 1,018 shares were disposed of at a price of $15.33 per share for tax withholding related to RSUs granted on February 28, 2022.
- Also on March 1, 2026, an additional 6,410 shares were disposed of at $15.33 per share for tax withholding from RSUs granted on February 25, 2025.
- All transactions were made pursuant to a Rule 10b5-1(c) plan.
- Following these transactions, Hanlin Gao beneficially owns 994,652 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transactions represent routine tax-related dispositions of shares from vested restricted stock units, which is a common occurrence for executives with equity compensation and does not indicate a change in company fundamentals or executive sentiment.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that these transactions are routine for executives receiving equity compensation, as shares are often withheld or sold to cover tax liabilities upon the vesting of restricted stock units. This is a common practice across various industries, including the biotechnology and diagnostics sector where Fulgent Genetics operates.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Scientific Officer | NA | Hanlin Gao | NA | Reporting person's current role, no change indicated. |
Stakeholder Impact
- Shareholders: Minimal direct impact, as these are routine tax-related dispositions and do not reflect a change in the executive's long-term commitment or a significant shift in outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/28/2022 | Grant date of certain restricted stock units (RSUs) that vested, leading to tax withholding. |
| 02/26/2024 | Grant date of certain restricted stock units (RSUs) that vested, leading to tax withholding. |
| 02/25/2025 | Grant date of certain restricted stock units (RSUs) that vested, leading to tax withholding. |
| 02/26/2026 | Transaction date for the disposition of 897 shares for tax withholding. |
| 03/01/2026 | Transaction date for the disposition of 1,018 and 6,410 shares for tax withholding. |
| 03/02/2026 | Date the Form 4 was signed by Paul Kim as Attorney-in-Fact. |
Keywords
Fulgent Genetics, FLGT, Form 4, Insider Transaction, Restricted Stock Units, RSU, Tax Withholding, Gao Hanlin, Chief Scientific Officer, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.